NeuroSense Therapeutics (NRSN) Long-Term Deferred Tax (2021 - 2023)
NeuroSense Therapeutics' (NRSN) quarterly Long-Term Deferred Tax came in at $3.3 million in Q4 2023, up 101.03% year-over-year from $1.6 million in Q4 2022, and up 101.03% quarter-over-quarter from $1.6 million in Q4 2022.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends
NeuroSense Therapeutics has disclosed Long-Term Deferred Tax across 3 years of filings, most recently posting $3.3 million for Q4 2023.
- In Q4 2023, Long-Term Deferred Tax rose 101.03% year-over-year to $3.3 million; the TTM figure through Dec 2023 stood at $3.3 million (up 101.03% YoY), while the FY2023 annual figure was $3.3 million, up 101.03% from the prior year.
- Long-Term Deferred Tax came in at $3.3 million for Q4 2023 at NeuroSense Therapeutics, up from $1.6 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $3.3 million in Q4 2023 to a low of $953000.0 in Q4 2021.
- Average Long-Term Deferred Tax over 3 years is $2.0 million, with a median of $1.6 million recorded in 2022.
- Year-over-year, Long-Term Deferred Tax soared 73.03% in 2022 and soared 101.03% in 2023.
- Over 3 years, Long-Term Deferred Tax stood at $953000.0 in 2021, then soared by 73.03% to $1.6 million in 2022, then soared by 101.03% to $3.3 million in 2023.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $3.3 million in Q4 2023, $1.6 million in Q4 2022, and $953000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 953,000.00 |
API Access
NeuroSense Therapeutics Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();